Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results Demonstrating Substantial Increases in Complete Response Rates in Advanced Cutaneous Squamous Cell Carcinoma

2 years ago

55% objective response rate; 23% complete response rate in locally advanced cSCC 50% objective response rate; 13% complete response rate…

PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

2 years ago

REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company…

Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast

2 years ago

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology company dedicated to breaking through…

Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference

2 years ago

ALACHUA and TAMPA, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and…

Tilray Renews Distribution Agreement With Great North Distributors for Cannabis Sales Across Canada With Newly Expanded Brand Portfolio

2 years ago

Tilray Continues to Lead Cannabis Market Share Across CanadaLEAMINGTON, Ontario, July 27, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq:…

Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference

2 years ago

CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on…

Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023

2 years ago

DURHAM, N.C., July 27, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully…

NeuroMetrix Reports Q2 2023 Business Highlights

2 years ago

WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the…

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2023

2 years ago

BANNOCKBURN, Ill., July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH),…

Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million

2 years ago

Second Quarter 2023 Conference Call and Webcast to be held August 10, 2023 at 8:00 a.m. Eastern Time Company plans…